# GHK-Cu: The Copper Tripeptide Research Record — Dr GHK-Cu

> GHK-Cu has been studied across skin, hair follicles, wound repair, pulmonary models, and neural gene expression. Every stat in this digest is indexed, cited, and sourced from peer-reviewed literature.

A 16-bit field guide to the peer-reviewed copper peptide GHK research record. Every level a different tissue, every card a cited finding.

## What Does GHK-Cu Do?

GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine. Three amino acids, one copper ion, and a research record that spans skin dermatology, wound biology, pulmonary science, and neural gene expression. In fibroblast cultures, GHK-Cu stimulates collagen synthesis starting at picomolar concentrations (10^-12 M), with maximum effect at 10^-9 M [1]. In a 12-week human study, topical GHK-Cu improved collagen density in 70% of treated subjects — higher than the vitamin C arm (50%) and the retinoic acid arm (40%) [2]. The literature covers over 50 peer-reviewed studies and more than 3,000 citations.

For [GHK-Cu dosage in the research literature](/dosage), see the dedicated dosage page. For the full study index, see [copper peptide GHK research](/research).

## What Is GHK-Cu? Molecular Structure and Natural Occurrence

GHK-Cu is the copper(II) chelate of the tripeptide glycyl-L-histidyl-L-lysine (GHK), a sequence naturally found in human plasma albumin, collagen type I, and the matricellular glycoprotein SPARC/osteonectin. Plasma concentrations average approximately 200 ng/mL in young adults and decline to approximately 80 ng/mL by age 60 [3]. The copper ion is not decorative — it is mechanistically essential. The copper moiety facilitates lysyl oxidase function for connective tissue crosslinking, while the tripeptide backbone activates TGF-beta, VEGFR2, and integrin-linked kinase signaling to stimulate extracellular matrix synthesis [4].

## GHK vs. GHK-Cu: The Role of Copper

GHK is the tripeptide backbone alone (glycyl-histidyl-lysine). GHK-Cu is the copper-chelated form. The distinction matters in the laboratory: collagen-stimulating assays show the copper moiety is required for the peptide's biological activity [1]. The copper coordinates to the nitrogen of the glycine residue and the imidazole of histidine, forming a square-planar complex that holds the copper ion in a biologically accessible oxidation state. Without the copper, the tripeptide sequence retains some angiogenic signaling from the SPARC-derived backbone, but the full range of gene-expression effects requires the metal chelate [4].

## GHK-Cu as a Copper Tripeptide: Structure and Biology

Copper tripeptide is the functional chemistry class, and Tripeptide-1 (INCI: Copper Tripeptide-1) is the name it carries in cosmetic ingredient databases. The molecular weight is 403.9 Da as the full copper complex (CuC14H22N6O4), and the hydrophilicity (clogP -2.24) limits passive diffusion through the stratum corneum — which is why advanced delivery formats (liposomal, palmitoylated, nanolipid carrier) are the active frontier of formulation research [5]. In a permeation study using human ex vivo skin, copper delivered as the GHK-Cu tripeptide penetrated full-thickness dermatomed skin with a permeability coefficient of 2.43 x 10^-4 cm/h over 48 hours, with the stratum corneum accumulating 438-fold over baseline — amounts described by the authors as therapeutically relevant [6].

## Copper Tripeptide-1 (Tripeptide-1): INCI Name and Relationship to GHK-Cu

Copper Tripeptide-1 is the INCI cosmetic ingredient name for GHK-Cu, also indexed as Tripeptide-1 in formulation databases. The terms refer to the identical molecular complex. In topical cosmetic products, GHK-Cu is formulated within regulations governing cosmetic ingredients rather than drug actives. The research literature uses GHK-Cu interchangeably with copper tripeptide, Copper Tripeptide-1, and the older "GHK copper" notation from Pickart's founding papers.

## GHK-Cu Anti-Aging Research: Skin, Cognition, and Longevity Studies

Anti-aging is the consumer framing; the peer-reviewed record is more specific. In dermatology, the dominant evidence is collagen density and wrinkle depth measured over 8–12 weeks in controlled human trials [2][5]. In gene expression, a bioinformatic analysis of public datasets found GHK modulating approximately 4,000 human genes — including upregulation of collagen, fibronectin, and basement membrane proteins, and downregulation of pro-inflammatory cytokines and tumor-promoting genes [4]. The plasma-concentration decline (200 → 80 ng/mL from age 20 to 60) [3] has been proposed as a mechanistic link between falling GHK levels and age-associated changes in tissue repair capacity — but the causal direction has not been established in an interventional human trial. In aged mice, intranasal GHK at 15 mg/kg daily improved Y-maze and Box Maze performance over 2 months and reduced NFL-1 (axonal damage marker) and MCP-1 (neuroinflammation) [7]. The literature is growing.

For [frequently asked questions about GHK-Cu](/faq), the FAQ covers the 29 most common research questions.

## GHK-Cu in Human Biology: Natural Plasma Levels

Endogenous GHK plasma concentrations average approximately 200 ng/mL in young adults (20s) and decline to approximately 80 ng/mL by age 60 [3]. This age-related decrease correlates with the well-documented decline in tissue repair capacity associated with aging — wound healing slows, collagen synthesis rates fall, and dermal architecture thins. The correlation is mechanistically plausible given GHK-Cu's documented roles in fibroblast signaling, extracellular matrix gene upregulation, and antioxidant pathway activation. Causal evidence from human interventional trials establishing a direct link between plasma GHK repletion and improved tissue repair outcomes has not yet been published.

## GHK-Cu Molecular Properties

GHK-Cu has a molecular weight of approximately 340.4 Da as the free tripeptide, and approximately 403.9 Da as the copper complex (CuC14H22N6O4). Its small size facilitates transdermal penetration relative to larger peptides, but the hydrophilicity (clogP -2.24) limits passive diffusion through the lipophilic stratum corneum barrier. Liposomal encapsulation, palmitoylation, and nanolipid carriers improve delivery. The small MW also enables potential systemic bioavailability via non-topical routes studied in animal models.

---

A 16-bit field guide to the copper peptide GHK literature — every study indexed, every stat cited, no coins spent on a clinic.